• 한국콘텐츠학회논문지
• /
• 제12권12호
• /
• pp.714-720
• /
• 2012

임상 연구에서 가장 중요한 것은 임상 자료를 정확하게 수집하는 것이다. 이를 위해, 최근 많은 제약회사들과 임상 연구기관에서는 전자 증례기록지(electronic Case Report Form, eCRF)를 도입하려고 노력하고 있다. eCRF는 임상연구에서 임상 자료를 수집하고 관리하기 위해 디자인된 컴퓨터 시스템이다. 하지만, 임상연구에서 eCRF의 중요성을 인식하고 있지만, eCRF 도입 초기에 많은 노력과 비용이 소요되기 때문에 널리 사용되고 있지는 못한다. 본 연구에서는 한의학연구원에서 임상연구를 위해 개발된 eCRF의 사용현황을 실증적 자료를 바탕으로 조사했다. 특히, eCRF에 자료를 입력하는데 걸리는 시간, 사용 시간, 쿼리 수 등을 시간적 흐름에 따른 변화에 중점을 두었다.

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1994년도 제3차 춘계학술대회
• /
• pp.7-7
• /
• 1994

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1994년도 제3차 춘계학술대회
• /
• pp.8-8
• /
• 1994

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 2006년도 제15차 추계학술대회
• /
• pp.127-128
• /
• 2006

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2005년도 추계학술대회
• /
• pp.39-45
• /
• 2005

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1993년도 제2차 춘계 심포지움
• /
• pp.7-7
• /
• 1993

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1993년도 제2차 춘계 심포지움
• /
• pp.5-5
• /
• 1993

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1993년도 제2차 춘계 심포지움
• /
• pp.9-9
• /
• 1993

• 한방안이비인후피부과학회지
• /
• 제30권2호
• /
• pp.1-18
• /
• 2017

Objectives : This review aims to evaluate a risk of bias by risk of bias tool and RoBANS(Risk of Bias Assessment tool for Non-randomized Study) tool for clinical trial papers proving treatment effect of Korean medicines to alopecia and provides the newest reason of effectiveness of herbs to alopecia. Methods : Data were collected through electronic database including NDSL, KISS, KMBASE, Koreantk, OASIS, KoreaMed, KISTI, Pubmed, Cochrane CENTRAL and CINAHL. Two experts in Oriental Medicine assessed risk of bias of randomized controlled trials by Cochrane group's Risk of Bias tool and non-randomized controlled trials by RoBANS tool after searching, reviewing and selecting papers. Results : Total number of selected trials is 20 including 4 randomized controlled trial, 13 non-randomized controlled trials and 3 case reports. This study evaluate the risk of bias of 17 papers including 4 randomized controlled trials and 13 non-randomized controlled trials except 3 case reports by risk of bias tool and RoBANS tool. All papers of randomized controlled trials are evaluated unclear for random sequence generation and allocation concealment as there are no word on them. And all papers of non-randomized controlled trials are evaluated unclear for blinding of outcome assessments and relatively low for others. Conclusions : Korean medicine intervention can be an effective for treatment in alopecia. It was evaluated by hair density, thickness and expert panel assessment of photographs and all results are statistically significant. But enhancing levels of evidence, we must try to reduce bias in researches and report a safety, protocol and IRB.

• 한방재활의학과학회지
• /
• 제27권3호
• /
• pp.95-105
• /
• 2017

Objectives To evaluate the evidence supporting the effectiveness of Soyeom pharmacopuncture therapy for Pain. Methods We conducted search across 6 electronic databases (Pubmed, CAJ, Oasis, RISS, DBPIA and KoreanTK) and 2 journals to find clinical trials that used Soyeom pharmacopuncture therapy as treatment for pain. The methodological quality of Randomized controlled clinical trials (RCTs) was assessed using the Cochrane Risk of Bias (RoB) tool, while NRCTs (Non-Randomized controlled clinical trials) were assessed using the Risk of Bias Assessment tool for Non-randomized Study (RoBANS) tool. Results Among 75 articles that were searched, 5 RCTs and 2 NRCTs were finally selected. Among 7 selected studies, all studies showed that Soyeom pharmacopuncture therapy has significant effect on Pain. Conclusions Our systematic review found encouraging but limited evidence of Soyeom pharmacopuncture therapy for Pain. We recommend clinical trials which compare the effectiveness of Soyeom pharmacopuncture therapy with other pharmacopuncture therapies to clarify the effectiveness of Soyeom pharmacopuncture therapy from other pharmacopuncture therapies.